Cognitive Impairment in Atrial Fibrillation

Status unconfirmed

Conditions studied: Atrial Fibrillation, Mild Cognitive Impairment, Dementia

In brief

This study aims to compare the incidence of new-onset cognitive impairments and change in existing impairment status between AF patients undergoing either catheter ablation or remaining on anti-arrhythmic drugs (AAD) as assessed by Montreal Cognitive Assessment (MoCA).

Key facts

Study ID

NCT01816308

Run by

Texas Cardiac Arrhythmia Research Foundation

People needed

888

Starts

2014-07-01

Expected to finish

2022-12-01

Last updated by the study team

2019-09-09

Who can join

Age: 50 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age: ≥ 50 years, male or female subjects
• Clinical diagnosis of AF
• Ability to provide written, informed consent

You may not qualify if…

• Patients with established dementia
• MoCA score ≤ 17 on Montreal Cognitive Assessment (MoCA)
• Use of illicit drugs
• Alcohol use: >12 drinks/week on average
• Clinical evidence of delirium or altered mental status
• Medically unstable patients (acute/unstable or poorly controlled problems that would demand focused, relatively urgent or emergent medical attention)

Where it is running

• Texas Cardiac Arrhythmia Institute, St. david's Medical Center — Austin, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.